EVO ICL Princeton, Monroe Township, & Somerset, NJ

Name: EVO ICL
Brand: Princeton Eye Group
Rating: 3.91 (295 reviews)

The EVO Implantable Collamer Lens is a premium vision correction procedure that delivers exceptional clarity without removing any corneal tissue, offering a compelling alternative to laser vision correction for patients seeking freedom from glasses and contact lenses.

woman smiling at a man holding an eye model with intraocular lenses

Vision Correction That Works With Your Eye

For patients who have been told they are not candidates for LASIK, or who simply prefer an approach that does not permanently alter their corneal tissue, the EVO ICL represents one of the most exciting advances in refractive surgery of the past two decades. Rather than reshaping the cornea with a laser, the EVO ICL is a thin, biocompatible lens implanted between the iris and the natural crystalline lens, where it works in harmony with the eye's existing optics to deliver precise, high-quality vision correction. It requires no removal of corneal tissue, produces no dry eye, and is removable if circumstances ever change. For patients with high prescriptions, thin corneas, or significant dry eye who have felt that vision correction was out of reach, the EVO ICL opens a door that laser vision correction cannot.

What Is the EVO ICL?

The EVO Implantable Collamer Lens is a small, flexible posterior chamber phakic intraocular lens made from Collamer. This proprietary biocompatible material incorporates a small amount of collagen, allowing it to integrate naturally with the eye's biology. The lens is implanted through a small incision in a brief outpatient procedure and positioned in the posterior chamber, behind the iris and in front of the natural crystalline lens, where it remains permanently but can be removed if needed. The EVO ICL corrects nearsightedness and astigmatism across a broad prescription range, including high myopia that falls outside the treatable range for LASIK or PRK. A built-in UV filter provides continuous protection from ultraviolet light. The EVO ICL does not touch the cornea, supports healthy tear film stability, and preserves the natural crystalline lens, meaning the eye retains its natural focusing ability for near vision.

The Benefits of EVO ICL

No Corneal Tissue Removed: Unlike LASIK and PRK, the EVO ICL corrects vision without removing or reshaping any corneal tissue, making it an ideal option for patients with thin corneas or those who prefer a non-ablative approach.
Exceptional Visual Quality: Clinical studies consistently demonstrate that the EVO ICL produces outstanding visual outcomes, with many patients achieving better quality of vision than they had with their best glasses or contact lenses, including improved contrast sensitivity and low-light performance.
Treats High Myopia: The EVO ICL corrects a broader range of nearsightedness than laser vision correction, making it an excellent option for patients with higher prescriptions who fall outside the safe treatable range for LASIK or PRK.
No Dry Eye: Because the EVO ICL does not affect the corneal nerves responsible for tear production, it does not cause the post-operative dry eye that some patients experience following laser vision correction, a significant advantage for patients who already have dry eye tendencies.
Removable and Reversible: Unlike laser vision correction, which permanently alters the cornea, the EVO ICL can be removed if the patient's prescription changes significantly or if circumstances require a different approach, providing a level of flexibility that no laser procedure can offer.
Built-In UV Protection: The Collamer material of the EVO ICL incorporates a built-in UV filter, providing continuous protection from ultraviolet light that complements, rather than replaces, the use of sunglasses.

EVO ICL: A Different Path to Visual Freedom

The EVO Implantable Collamer Lens (ICL) is a soft, biocompatible lens placed behind the iris to correct nearsightedness, offering an alternative to glasses and contacts without altering the eye's natural structure. Watch this quick video to see how the procedure works, from initial measurements to final placement.

Is the EVO ICL Right for Me?

EVO ICL in NJ is an excellent option for patients between the ages of 21 and 45 with moderate to high myopia, stable prescriptions, and sufficient anterior chamber depth to accommodate the lens safely. It is particularly well-suited for patients who have been told they are not candidates for LASIK due to thin corneas, dry eye, or prescriptions outside the laser treatable range, as well as patients who prefer an additive, reversible approach to vision correction. Patients with certain anterior segment conditions, a history of iritis or uveitis, or insufficient anterior chamber depth may not be appropriate candidates. A comprehensive refractive evaluation at Princeton Eye Group, including detailed anterior segment imaging and biometry, will determine whether the EVO ICL is the right choice for your eyes and goals.

The EVO ICL Process What to Expect

Comprehensive Refractive Evaluation

Your surgeon will perform a thorough assessment of your prescription, corneal health, anterior chamber depth, and overall ocular anatomy to confirm your candidacy for the EVO ICL and determine the correct lens power and size for your eye.

Pre-Operative Preparation

Contact lens wearers must discontinue lens use for a specified period prior to surgery to allow the cornea to return to its natural shape. Your surgeon will provide specific instructions regarding pre-operative preparations and what to arrange for the day of your procedure.

Procedure Day

EVO ICL implantation is performed on an outpatient basis under topical anesthesia. A small incision is made at the edge of the cornea, the folded lens is gently inserted through the incision and positioned in the posterior chamber behind the iris, and the incision self-seals without sutures. The procedure takes approximately 20 to 30 minutes per eye. Both eyes are typically treated on the same day, though some patients prefer to stage the procedures and have each eye done separately.

Immediate Recovery

Most patients notice a significant improvement in vision within the first 24 hours following the implantable collamer lens. Some mild light sensitivity and blurring are normal in the first day or two and resolve quickly. A brief follow-up appointment is scheduled for the day after surgery to confirm the lens position and early healing.

Visual Stabilization and Follow-Up

Final visual outcomes are typically appreciated within the first week following surgery, significantly faster than PRK. Your surgeon will monitor your vision, lens position, and intraocular pressure at a series of follow-up appointments to confirm the stability and accuracy of the outcome.

Your EVO ICL Results and Recovery

EVO ICL recovery is fast and straightforward. Most patients notice dramatic improvement in vision within 24 hours and return to normal daily activities within one to two days of surgery. The lens begins working immediately upon implantation, and there is no healing or adaptation period comparable to that of PRK. Visual outcomes with the EVO ICL are consistently excellent, with the majority of patients achieving their target refraction and many reporting vision quality that surpasses what they experienced with glasses or contacts. Because the natural crystalline lens is preserved, patients retain their ability to accommodate for near vision, an important consideration for younger patients who are not yet presbyopic. Long-term satisfaction rates with the EVO ICL are among the highest of any vision correction procedure.

Schedule a Free Consultation

Why Choose Princeton Eye Group for EVO ICL?

Princeton Eye Group offers the subspecialty depth, surgical expertise, and comprehensive evaluation process necessary to deliver the full potential of EVO ICL surgery to patients throughout New Jersey.

A Full Spectrum of Vision Correction Options

Princeton Eye Group offers every major vision correction modality, including LASIK, PRK, EVO ICL, and custom lens replacement. This means that EVO ICL recommendations are made because it is genuinely the best option for the patient, not because it is the only option available. Patients receive an honest, unbiased assessment of all available procedures during their consultation.

Expert Anterior Segment Evaluation

EVO ICL candidacy depends on a precise assessment of anterior chamber depth, corneal health, and ocular anatomy. Princeton Eye Group's corneal and refractive specialists bring fellowship-level anterior segment expertise to every ICL evaluation, ensuring that sizing, positioning, and lens selection are optimized for the safest and most precise outcome.

Subspecialty Support for Complex Cases

Patients considering the EVO ICL with coexisting conditions such as dry eye, corneal irregularity, or prior refractive surgery benefit from the input of Princeton Eye Group's full subspecialty team, a level of integrated evaluation that standalone refractive centers cannot provide.

Complimentary Consultations

As with all vision correction procedures at Princeton Eye Group, EVO ICL consultations are offered at no charge and with no obligation, giving every patient the opportunity to explore their options in a thorough, unhurried setting.

Convenient Locations Across Central New Jersey

With offices in Princeton, Monroe Township, and Somerset, Princeton Eye Group makes expert EVO ICL care accessible to patients throughout the region in a physician-led, welcoming environment.

Affordable Vision Correction, Transparent Pricing

At Princeton Eye Group, vision correction is priced simply and honestly. Our global fee covers everything—the surgeon's fee, facility fee, laser royalties, eye drops, and all necessary follow-up care—with no hidden upcharges for higher prescriptions, astigmatism, or additional testing. The fee is the same regardless of the complexity of your case.

For patients who prefer to spread the cost over time, we offer flexible monthly payment options through CareCredit. HSA and FSA funds are also accepted, allowing you to use pre-tax dollars toward your investment in better vision.

Learn More About Financing

EVO ICL Frequently Asked Questions

What is the difference between the EVO ICL and LASIK?

LASIK uses an excimer laser to permanently reshape the cornea, while the EVO ICL is a lens implanted behind the iris that corrects vision without touching or altering the cornea. LASIK is generally preferred for patients within the laser-treatable prescription range with healthy corneas. At the same time, the EVO ICL is better suited for patients with higher prescriptions, thin corneas, dry eye, or a preference for a reversible approach.

Is the EVO ICL permanent?

The EVO ICL is designed as a permanent implant, but is removable if circumstances change. Unlike laser vision correction, which permanently alters the corneal tissue, the EVO ICL can be explanted and replaced with a different lens or prescription if needed — providing a degree of flexibility that laser procedures cannot offer.

Does the EVO ICL cause dry eye?

No. Because the EVO ICL does not affect the corneal nerves responsible for regulating tear production, it does not cause the post-operative dry eye that some patients experience following LASIK or PRK. This makes it particularly advantageous for patients who already experience dry eye symptoms or are concerned about worsening dry eye after vision correction.

Can the EVO ICL correct astigmatism?

Yes. The EVO ICL is available in a toric version that simultaneously corrects myopia and astigmatism, providing comprehensive refractive correction for patients with both conditions.

Will I be able to feel the EVO ICL in my eye?

No. The EVO ICL is positioned entirely behind the iris and is not visible or palpable. The vast majority of patients are completely unaware of the lens after the initial healing period.

What happens to the EVO ICL if I eventually develop cataracts?

If a cataract develops in the natural crystalline lens later in life, the EVO ICL can be removed at the time of cataract surgery and replaced with an intraocular lens. The presence of an EVO ICL does not prevent cataract surgery from being performed in the future.

How quickly will I see results after EVO ICL implantation?

Most patients notice a significant improvement in vision within 24 hours of ICL eye surgery, with final visual stabilization typically occurring within the first week. Recovery is considerably faster than PRK and comparable to LASIK.

Does insurance cover the EVO ICL?

The EVO ICL is an elective refractive procedure and is not covered by most medical insurance plans. FSA and HSA funds are generally accepted, and financing options are available. Your surgeon will discuss all costs during your complimentary consultation.